论文部分内容阅读
目的观察无创正压通气(NPPV)治疗慢性阻塞性肺疾病(COPD)并Ⅱ型呼吸衰竭的疗效。方法慢性阻塞性肺疾病并Ⅱ型呼吸衰竭患者56例,随机将所有患者分为试验组和对照组,每组28例,试验组经口鼻面罩进行NPPV,选择S/T通气模式;对照组仅给予常规治疗,包括抗感染、祛痰、平喘等治疗。比较两组患者的血气分析、预后情况和住院时间。结果试验组较对照组治疗后的p H值、Pa O2、Sa O2改善更明显,与对照组治疗后比较差异有统计学意义(P<0.05);试验组治愈26例,对照组治愈18例,两组预后情况比较差异具有统计学意义(P<0.05);试验组住院时间(10.1±2.5)d,较对照组(21.6±6.9)d明显更短,差异具有统计学意义(P<0.05)。结论 NPPV治疗COPD并Ⅱ型呼吸衰竭能明显改善患者的预后,减少住院时间,疗效显著。
Objective To observe the curative effect of noninvasive positive pressure ventilation (NPPV) on chronic obstructive pulmonary disease (COPD) and type Ⅱ respiratory failure. Methods Fifty-six patients with chronic obstructive pulmonary disease and type Ⅱ respiratory failure were randomly divided into experimental group and control group, with 28 cases in each group. The experimental group received NPPV via oral or nasal mask and S / T ventilation mode was selected. In the control group Only given conventional treatment, including anti-infective, expectorant, asthma and other treatment. Blood gas analysis, prognosis and hospital stay were compared between the two groups. Results Compared with the control group, the values of p H, Pa O2 and Sa O2 were significantly improved in the experimental group compared with those in the control group (P <0.05). The experimental group was cured in 26 cases and the control group was cured in 18 cases (P <0.05). The length of hospital stay in the experimental group was (10.1 ± 2.5) d, which was significantly shorter than that in the control group (21.6 ± 6.9) d, the difference was statistically significant (P <0.05) ). Conclusion NPPV treatment of COPD and type Ⅱ respiratory failure can significantly improve the prognosis of patients, reduce hospitalization time, the effect is significant.